Sofia D. Merajver
Affiliations: | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
Epidemiology, Public Health, Molecular BiologyGoogle:
"Sofia Merajver"Cross-listing: PHTree
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Laws A, Leonard S, Hershey E, et al. (2024) ASO Visual Abstract: Upgrade Rates and Breast Cancer Development Among Germline Pathogenic Variant Carriers with High-Risk Breast Lesions. Annals of Surgical Oncology |
| Laws A, Leonard S, Hershey E, et al. (2024) Upgrade Rates and Breast Cancer Development Among Germline Pathogenic Variant Carriers with High-Risk Breast Lesions. Annals of Surgical Oncology |
| Liu Y, Joy ST, Henley MJ, et al. (2023) Inhibition of CREB Binding and Function with a Dual-Targeting Ligand. Biochemistry |
| Daly MB, Pal T, Maxwell KN, et al. (2023) NCCN GuidelinesĀ® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024. Journal of the National Comprehensive Cancer Network : Jnccn. 21: 1000-1010 |
| Fleege NMG, Pierce-Gjeldum D, Swartz LK, et al. (2022) IMPACT the Brain: A Team-Based Approach to Management of Metastatic Breast Cancer With CNS Metastases. Jco Oncology Practice. OP2200291 |
| Abraham HG, Ulintz PJ, Goo L, et al. (2021) RhoC Modulates Cell Junctions and Type I Interferon Response in Aggressive Breast Cancers. Frontiers in Oncology. 11: 712041 |
| Lloyd JP, Soellner MB, Merajver SD, et al. (2021) Impact of between-tissue differences on pan-cancer predictions of drug sensitivity. Plos Computational Biology. 17: e1008720 |
| Jiagge EM, Ulintz PJ, Wong S, et al. (2021) Multiethnic PDX models predict a possible immune signature associated with TNBC of African ancestry. Breast Cancer Research and Treatment |
| Daly MB, Pal T, Berry MP, et al. (2021) Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : Jnccn. 19: 77-102 |
| Bhatia S, Palomares MR, Hageman L, et al. (2020) A Randomized Phase IIb Study of Low-dose Tamoxifen in Chest-irradiated Cancer Survivors at risk for Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |